+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Growth Hormone Secretagogue"

Endocrinology Drugs Market Report 2025 - Product Thumbnail Image

Endocrinology Drugs Market Report 2025

  • Report
  • April 2025
  • 175 Pages
  • Global
From
Ghrelin Receptor Agonists - Pipeline Insight, 2025 - Product Thumbnail Image

Ghrelin Receptor Agonists - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Somatotropin Deficiency - Pipeline Insight, 2025 - Product Thumbnail Image

Somatotropin Deficiency - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
  • 4 Results (Page 1 of 1)
Loading Indicator

Growth Hormone Secretagogues (GHSs) are a class of drugs used to treat endocrine and metabolic disorders. They are used to stimulate the release of growth hormone from the pituitary gland, which helps to regulate metabolism, body composition, and other physiological processes. GHSs are used to treat growth hormone deficiency, as well as other conditions such as Prader-Willi Syndrome, Turner Syndrome, and idiopathic short stature. GHSs are also used off-label to treat obesity, muscle wasting, and other conditions. GHSs are available in both oral and injectable forms, and are typically prescribed in combination with other medications. Common side effects of GHSs include headache, nausea, and dizziness. Some companies in the Growth Hormone Secretagogue market include Novo Nordisk, Pfizer, Eli Lilly, and Ipsen. Show Less Read more